E-cigarette use in reproductive-aged women and pregnancy: a rising health concern

Inklings

Go to the profile of Fertility and Sterility
Fertility and Sterility
Editorial Office, American Society for Reproductive Medicine
Published
Like Comment
Related Content

Volume 113, Issue 6, Pages 1133–1134

Authors:

Shruti Agarwal, D.O., Mark P. Trolice, M.D., Steven R. Lindheim, M.D., M.M.M.

Abstract:

As of December 2019, the Centers for Disease Control and Prevention and media have highlighted the sudden spike in cases of EVALI, a newly coined acronym meaning electronic-cigarette (e-cigarette) or vaping-associated lung injury, with >2,500 cases requiring hospitalization and >50 fatalities in the United States. These new data are concerning as e-cigarette use among reproductive-aged women appears to be steadily increasing. In addition, although 18%–25% of women quit once pregnant, many supplement or replace tobacco products with e-cigarette use. This has not proven to be effective.

 

Read the full text here.

Go to the profile of Fertility and Sterility

Fertility and Sterility

Editorial Office, American Society for Reproductive Medicine

Fertility and Sterility® is an international journal for obstetricians, gynecologists, reproductive endocrinologists, urologists, basic scientists and others who treat and investigate problems of infertility and human reproductive disorders. The journal publishes juried original scientific articles in clinical and laboratory research relevant to reproductive endocrinology, urology, andrology, physiology, immunology, genetics, contraception, and menopause. Fertility and Sterility® encourages and supports meaningful basic and clinical research, and facilitates and promotes excellence in professional education, in the field of reproductive medicine.